2015 annual financial data
Tenax Therapeutics 2015 Operating cash flow margin
Direct answer
Operating cash flow margin was -19,780.05%.
Operating income was -15,638,247 USD and net income was -14,081,812 USD.
Operating cash flow was -9,748,794 USD.
Get free Tenax Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 49,286 USD
- Operating income
- -15,638,247 USD
- Net income
- -14,081,812 USD
- Operating cash flow
- -9,748,794 USD